KRAS IN-44
Product Specifications
Target
PDE, PI3K, Akt, Apoptosis, Ras, mTOR
Related Pathways
Cytoskeletal Signaling, MAPK, PI3K/Akt/mTOR signaling, Metabolism, Apoptosis
Bioactivity
KRAS IN-44 (Compound S2C2M2) is a PDE6D degrader. It inhibits PDE6D-dependent KRAS transport and downstream signaling pathways. Additionally, KRAS IN-44 downregulates EGF-induced phosphorylation of PI3K, AKT, and mTOR. It promotes apoptosis and exhibits antitumor activity against hepatoblastoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog